Objectives

  • Learning Objective 1: Explain the key clinical features of cannabinoid hyperemesis syndrome.
  • Learning Objective 2: Describe the mechanism of cannabinoid hyperemesis syndrome.
  • Learning Objective 3: Describe newer treatment options for cannabinoid hyperemesis syndrome.
Session date: 
Thursday, August 23, 2018 - 8:00am to 9:00am
Speaker Name: 
Alisha Patel, PharmD
Location: 
UCM
5841 S. Maryland Ave., MC 5068
L-523
Chicago, IL 60637
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.